Synopsis
As more SCS systems that provide multiple neurostimulation approaches continue to become available, it will be necessary to evaluate usage of these devices and associated clinical outcomes. In this study, long-term outcomes were assessed in patients using a new SCS system designed to customize SCS using combination therapy, waveform automation, and a device algorithm engineered for manipulatable control of stimulation field shape. Twenty-three percent of all patients reported being pain free (NRS = 0) at last follow-up. Given the variability of experience associated with chronic pain, the SCS-implanted patient population may particularly benefit from devices that enable individualized treatment customization.
Disclosures
- Mr. Hammond reports personal fees from Orthomicrospine and personal fees from Boston Scientific.
- Dr. Pyles has received speaker honoraria from and is a consultant for Boston Scientific.
- Dr. Waghmarae is a consultant for Boston Scientific. Dr. North is a consultant for Boston Scientific.
- Dr. Berg is a consultant for Boston Scientific.
- Drs. Metzger and Washabaugh report no relevant conflicts of interest.
- Ms. Jain and Ms. Pei are salaried employees of Boston Scientific.
- This study was sponsored by Boston Scientific.
Author(s):
- Clark S. Metzger, MD, NeuroMicroSpine
- M. Blake Hammond, PA, West Florida Orthopedics and Spine Surgery
- Stephen T. Pyles, MD, Interventional Pain Management Physician, Pain Treatment Centers
- Dr. Edward P. Washabaugh III, MD, FIPP, Forest Health Medical Center
- Dr. Romanth Waghmarae, MD, DABA, FIPP, Medical Director, Advanced Pain and Wellness Institute
- Anthony P. Berg, MD, Interventional Pain Management Physician, Spine Team Texas
- Dr. James M. North, MD, The Center for Clinicial Research, LLC
- Yu Pei, MPA, Statistical Programmer, Boston Scientific
- Roshini Jain, MS, Clinical Research, Director, Boston Scientific Neuromodulation
| Display Label | Action |
|---|---|
| Abstract - NPC2021 Meztger Long-Term Pain Relief | Download Abstract |
| Poster - NPC2021 Meztger Long-Term Pain Relief | Download Poster |
Please use this thread to discuss the following:
Long-Term Pain Relief Using an SCS Device Capable of Simultaneous Combination Therapy and Dorsal Horn Modulation
Synopsis
As more SCS systems that provide multiple neurostimulation approaches continue to become available, it will be necessary to evaluate usage of these devices and associated clinical outcomes. In this study, long-term outcomes were assessed in patients using a new SCS system designed to customize SCS using combination therapy, waveform automation, and a device algorithm engineered for manipulatable control of stimulation field shape. Twenty-three percent of all patients reported being pain free (NRS = 0) at last follow-up. Given the variability of experience associated with chronic pain, the SCS-implanted patient population may particularly benefit from devices that enable individualized treatment customization.
Disclosures
- Mr. Hammond reports personal fees from Orthomicrospine and personal fees from Boston Scientific.
- Dr. Pyles has received speaker honoraria from and is a consultant for Boston Scientific.
- Dr. Waghmarae is a consultant for Boston Scientific. Dr. North is a consultant for Boston Scientific.
- Dr. Berg is a consultant for Boston Scientific.
- Drs. Metzger and Washabaugh report no relevant conflicts of interest.
- Ms. Jain and Ms. Pei are salaried employees of Boston Scientific.
- This study was sponsored by Boston Scientific.